Analystreport

Fate Therapeutics, Inc. (NASDAQ: FATE) is now covered by analysts at Robert W. Baird. They set a "neutral" rating on the stock.

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations